Medicare Enrolled

Dr. Howard Ying, M.D.,PH.D.

Ophthalmology · Cambridge, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5 JFK ST STE 302, Cambridge, MA 02138
6176579464
In practice since 2006 (20 years)
NPI: 1841236791 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ying from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ying? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ying

Dr. Howard Ying is an ophthalmology specialist in Cambridge, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ying performed 44,744 Medicare services across 3,684 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ying received a total of $9,005 from 26 pharmaceutical and/or device companies across 237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ying is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in MA $9,005 industry payments

Medicare Practice Summary

Medicare Utilization ↗
44,744
Medicare services
Top 0% in MA for ophthalmology
3,684
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,237 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
33,780 $29 $67
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
3,271 $32 $110
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
2,189 $98 $788
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
1,499 $54 $200
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,221 $88 $339
Aflibercept eye injection (Eylea) 844 $688 $2,200
Injection, ranibizumab, 0.1 mg 520 $182 $825
Fluocinolone acetonide intravitreal implant
An implant containing fluocinolone acetonide is placed inside the eye to deliver medication directly to the vitreous.
380 $385 $1,230
Injection, bimatoprost, intracameral implant, 1 microgram 290 $160 $390
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
121 $47 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
112 $120 $450
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
111 $25 $100
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
106 $63 $240
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
63 $1,715 $3,518
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
52 $27 $140
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
44 $103 $402
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
33 $186 $1,500
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
31 $917 $3,100
Medication injection into the eye
A procedure involving the injection of medication directly into the eye. The specific type of medication or clinical purpose is not defined in the provided description.
29 $147 $560
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
20 $24 $300
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
16 $276 $1,000
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
12 $670 $2,350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,005
Total received (2018-2024)
Avg $1,286/year across 7 years
Top 13% in MA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
237
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,467 (82.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,538 (17.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,550
2023
$2,275
2022
$939
2021
$526
2020
$651
2019
$949
2018
$115

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alimera Sciences, Inc.
$1,538
ABBVIE INC.
$522
Mallinckrodt Hospital Products Inc.
$522
Genentech USA, Inc.
$285
Sandoz Inc.
$231
Astellas Pharma US Inc
$179
Regeneron Healthcare Solutions, Inc.
$98
Tarsus Pharmaceuticals, Inc.
$74
Coherus Biosciences Inc.
$40
ANI Pharmaceuticals, Inc.
$24
Dompe US, Inc.
$19
Amgen Inc.
$19
Top 3 companies account for 72.7% of 2024 payments
All-time payments by company (2018-2024) ›
Alimera Sciences, Inc.
$2,528
Mallinckrodt Hospital Products Inc.
$1,742
Genentech USA, Inc.
$713
ABBVIE INC.
$597
Astellas Pharma US Inc
$574
Alcon Vision LLC
$494
AbbVie Inc.
$464
Regeneron Healthcare Solutions, Inc.
$263
Sandoz Inc.
$231
Sun Pharmaceutical Industries Inc.
$211
EyePoint Pharmaceuticals US, Inc.
$145
Aerie Pharmaceuticals, Inc.
$144
Allergan Inc.
$144
Novartis Pharmaceuticals Corporation
$127
Horizon Therapeutics plc
$122
Coherus Biosciences Inc.
$105
Tarsus Pharmaceuticals, Inc.
$74
Mallinckrodt Enterprises LLC
$60
Apellis Pharmaceuticals, Inc.
$56
Allergan, Inc.
$56
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
Oyster Point Pharma, Inc.
$35
ANI Pharmaceuticals, Inc.
$24
AbbVie, Inc.
$20
Dompe US, Inc.
$19
Amgen Inc.
$19
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROMSITE · CEQUA · Cequa · Cimerli · Constellation · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Humira · ILUVIEN · Iluvien · Izervay · Lucentis · OXERVATE · OZURDEX · PURIFIED CORTROPHIN GEL · ReSTOR · Syfovre · TEPEZZA · TYRVAYA · VABYSMO · Vabysmo · XDEMVY · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · YUTIQ · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Cambridge?
Compare ophthalmologists in the Cambridge area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
523
Per 100K population
32.2
County median income
$126,779
Nearest hospital
MOUNT AUBURN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ying is a mixed practice specialist, with above-average Medicare volume (top 0% in MA), with low-engagement industry engagement in the top 13% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ying experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Ying performed 33,780 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ying receive payments from pharmaceutical companies?
Yes. Dr. Ying received a total of $9,005 from 26 companies across 237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ying's costs compare to other ophthalmologists in Cambridge?
Dr. Ying's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ying) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →